Is ACCURAY INC (ARAY) Halal?
Shariah Screening — 5 Standards
Based on financial data from June 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 302.8% / 30% | 98.6% / 30% | 168.0% / 30% | 0.26% / 5% | ✗ NOT HALAL |
| DJIM | 302.8% / 33% | 98.6% / 33% | 168.0% / 33% | 0.26% / 5% | ✗ NOT HALAL |
| MSCI | 37.5% / 33% | 12.2% / 33% | 20.8% / 33% | 0.26% / 5% | ✗ NOT HALAL |
| S&P | 302.8% / 33% | 98.6% / 33% | 168.0% / 33% | 0.26% / 5% | ✗ NOT HALAL |
| FTSE | 37.5% / 33% | 12.2% / 33% | 20.8% / 50% | 0.26% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 27.8% | |
| Operating Margin | 3.7% | |
| Net Margin | -8.2% | |
| Return on Equity (ROE) | -70.3% | |
| Return on Assets (ROA) | -1.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $3M |
| Free Cash Flow | -$6M |
| Total Debt | $176M |
| Debt-to-Equity | 289.7 |
| Current Ratio | 1.5 |
| Total Assets | $470M |
Price & Trading
| Last Close | $0.37 |
| 50-Day MA | $0.58 |
| 200-Day MA | $1.14 |
| Avg Volume | 1.1M |
| Beta | 1.2 |
|
52-Week Range
$0.33
| |
About ACCURAY INC (ARAY)
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is ACCURAY INC (ARAY) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ACCURAY INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ACCURAY INC's debt ratio?
ACCURAY INC's debt ratio is 302.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 37.5%.
What are ACCURAY INC's key financial metrics?
ACCURAY INC has a market capitalization of $47M, and revenue of $459M. The company maintains a gross margin of 27.8% and a net margin of -8.2%. Return on equity stands at -70.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.